Vox Markets Interview with Avacta CEO Alastair Smith
0
0
0 Vues·
09/19/23
Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.
Montre plus
0 commentaires
sort Trier par